1-8 of 8
Michael Taylor, PharmD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Changing Demographics and Treatment Patterns in Patients the United States with Chronic Lymphocytic Leukemia in the First-Line Setting As Assessed Using a Novel Electronic Health Record Database

Brandon Arnieri, MS, Coen Bernaards, MS, PhD, Kenneth Wilhelm, MD, James Black, PhD(Cantab) MPH MPhil, Ceri Hirst, PhD, Michael Taylor, PharmD, PhD, Peter Lambert, PhD, Kathryn Green, Michael Lu, Kathryn Humphrey, PhD
Journal: Blood
Blood (2016) 128 (22): 4787.
https://doi.org/10.1182/blood.V128.22.4787.4787
Published: 2016
Journal Articles

A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma (FL) Used in the United States

Loretta Nastoupil, MD, Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Brian K Link, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 97.
https://doi.org/10.1182/blood.V118.21.97.97
Published: 2011
Journal Articles

Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL)

Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Nutan J. DeJoubner, MD, Ajay K. Nooka, MD, MPH, FACP, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Brian K Link, MD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 775.
https://doi.org/10.1182/blood.V118.21.775.775
Published: 2011
Journal Articles

Characteristics and Effectiveness of Rituximab (R) Maintenance Regimens Among US Patients Diagnosed with Follicular Lymphoma (FL) 2004–2007,

Loretta Nastoupil, MD, Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Xiaolei Zhou, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Brian K Link, MD, Jamie H. Hirata, PharmD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 3708.
https://doi.org/10.1182/blood.V118.21.3708.3708
Published: 2011
Journal Articles

Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)

Christopher R Flowers, MD, MS, Michael Taylor, PharmD, PhD, Michelle Byrtek, PhD, Jamie H. Hirata, PharmD, James Cerhan, MD, PhD, John Hainsworth, MD, Brian Link, Thomas P. Miller, MD, Hildy Dillon, MPH, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2010) 116 (21): 1768.
https://doi.org/10.1182/blood.V116.21.1768.1768
Published: 2010
Journal Articles

Disease Characteristics and Patterns of Care In Elderly Patients (80+ years) with Follicular Lymphoma (FL) In the United States (US); Are Older Patients Treated Differently? Report From the National LymphoCare Study (NLCS)

Chadi Nabhan, MD, FACP, Michelle Byrtek, Ph.D., Michael Taylor, PharmD, PhD, Jill Tydell, MD, Jamie H. Hirata, PharmD, Christopher R Flowers, MD, MS
Journal: Blood
Blood (2010) 116 (21): 4152.
https://doi.org/10.1182/blood.V116.21.4152.4152
Published: 2010
Journal Articles

Risk Factors for Early Transformation of Follicular Lymphoma (FL): Report From the National LymphoCare Study (NLCS).

Nina D. Wagner-Johnston, MD, Brian K Link, MD, Michael Taylor, PharmD, PhD, Nancy L. Bartlett, MD
Journal: Blood
Blood (2009) 114 (22): 2698.
https://doi.org/10.1182/blood.V114.22.2698.2698
Published: 2009
Journal Articles

Racial Disparities in Disease Presentation, Treatment, and Response Rates of Follicular Lymphoma (FL) in the United States (US): Report From the National LymphoCare Study (NLCS).

Chadi Nabhan, MD, FACP, Michael Taylor, PharmD, PhD, Jamie Hirata, Ming Lin, Benjamin Parsons, Christopher R. Flowers, MD
Journal: Blood
Blood (2009) 114 (22): 1381.
https://doi.org/10.1182/blood.V114.22.1381.1381
Published: 2009